NEXTM is a winner!!! Bargain price today for a valuable product---with competent management.
Do you think Davita will buy them and if so at what price? It seems like at home dialysis can be the norm soon with the positive studies.
It's possible.Anything is--but NXTM is a winner.If it is bought out--look forb $15-20 per share.